Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-blinded Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome

NCT04244006 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT04244006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04244006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-blinded Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome
Lead sponsor
University Hospital, Toulouse
Phase
Phase 2/3
Overall status
Terminated
Start date
July 23, 2020
Completion date
November 15, 2022
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

netherton syndrome